0
Protalix BioTherapeutics, Inc.
- 201-500 Employees
- Based in Karmiel, Israel
Protalix BioTherapeutics, Inc., a biopharmaceutical company, through Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in the United States.
Social Media Links
Protalix BioTherapeutics, Inc.
Most Recent Annual Report
Protalix BioTherapeutics, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
